A consortium that includes Nestlé, PepsiCo, and Suntory has produced the world’s first food-grade PET plastic bottles from enzymatically recycled plastic using Carbios’ recycling process.
The bottles that have been produced are for such products as Perrier, Pepsi Max, and Orangina.
The consortium also includes Carbios and L’Oreal.
The production of the bottles is a major milestone that validates Carbios’ technology, which supercharges enzymes that occur in compost heaps and break down leaf membranes.
It took Carbios nearly ten years of research to develop its enzymatic recycling process.
Carbios has now ‘fine-tuned’ the technology and optimized the enzyme to break down any kind of plastic, regardless of color or complexity, into individual chemical components.
It takes 16 hours to break down 97 percent of plastic.
To accelerate the adoption of enzymatic recycling of all kinds of PET-based products, Carbios will license its technology worldwide.
The industrial chemistry firm will also break ground on a demonstration plant in September, before launching a 40,000 tonnes capacity industrial facility by 2025.
Jean Claude Lumaret, CEO of Carbios, describes their innovation as transformational as it finally fully closes the loop on PET plastic supply globally so that it never becomes a waste.
He added that they have proved the viability of their enzymatic recycling process with the world’s leading brands.
Michelle Norman, director of external affairs and sustainability, Suntory Beverage and Food Great Britain & Ireland, said that the process ensures that plastic stays in circulation and out of the environment, which is what they’re striving for.


Meta’s AI Shopping Push Grows as Agentic Commerce Remains Below 1%
SoftBank Shares Jump 8% as SB Energy IPO Optimism Builds
BOJ Set to Raise Rates to 1.25% as Inflation Risks Build
BOJ Flags Import Costs and Yen Shocks as Persistent Inflation Risks
SpaceX Nasdaq 100 Weight Set to More Than Double
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Saudi Oil Exports Face 4% Global Supply Threat as Pipeline Remains Shut
Volkswagen Job Cuts Put Lower Saxony Leader Under Political Pressure
Hyundai Delays In-House ADAS, Turns to Nvidia
Japanese Yen Retreats as Dollar Rises Ahead of Fed, BOJ Rate Decisions
Ex-Google DeepMind Researcher Warns AI Could Pose Existential Threat
Asian Stocks Steady as AI Shares Rebound Ahead of Fed Decision
US Futures Fall as Fed Meeting, Oil Surge Rattle Markets
Gold Prices Fall as Hot U.S. Inflation Boosts Fed Rate Hike Bets 



